Variant report
Variant | nsv983533 |
---|---|
Chromosome Location | chr13:87479232-87484215 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141477192 | chr13:87479242-87479243 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560039245 | chr13:87479255-87479256 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553411761 | chr13:87479290-87479291 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77291481 | chr13:87479344-87479345 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545414843 | chr13:87479346-87479347 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532189509 | chr13:87479364-87479365 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150867191 | chr13:87479383-87479384 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560104409 | chr13:87479409-87479410 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575675201 | chr13:87479455-87479456 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543270263 | chr13:87479495-87479496 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561895148 | chr13:87479501-87479502 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529178950 | chr13:87479529-87479530 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540887567 | chr13:87479545-87479546 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369456055 | chr13:87479559-87479560 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9515995 | chr13:87479611-87479612 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs369601932 | chr13:87479625-87479626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550941169 | chr13:87479663-87479664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9515996 | chr13:87479694-87479695 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs187050688 | chr13:87479703-87479704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74101959 | chr13:87479728-87479729 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs115802627 | chr13:87479745-87479746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564164932 | chr13:87479776-87479777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368850281 | chr13:87479863-87479864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534894983 | chr13:87479883-87479884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553748127 | chr13:87479890-87479891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571946778 | chr13:87479899-87479900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531294265 | chr13:87479939-87479940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185036942 | chr13:87482025-87482026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548586527 | chr13:87482026-87482027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566487850 | chr13:87482085-87482086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527668890 | chr13:87482233-87482234 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189838603 | chr13:87482242-87482243 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543101448 | chr13:87482298-87482299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183777278 | chr13:87482299-87482300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556841507 | chr13:87482316-87482317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71442155 | chr13:87482321-87482322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368472201 | chr13:87482350-87482351 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536108322 | chr13:87482366-87482367 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554560864 | chr13:87482394-87482395 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370928180 | chr13:87482421-87482422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540231783 | chr13:87482422-87482423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34962866 | chr13:87482438-87482439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528833624 | chr13:87482446-87482447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562557880 | chr13:87482456-87482457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558716122 | chr13:87482471-87482472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576998962 | chr13:87482474-87482475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544807285 | chr13:87482495-87482496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375164357 | chr13:87482536-87482537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531303857 | chr13:87482539-87482540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562913308 | chr13:87482545-87482546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:87478600-87480000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr13:87479000-87479600 | Active TSS | Brain Inferior Temporal Lobe | brain |
3 | chr13:87479400-87479600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:87479400-87479800 | Enhancers | Brain Cingulate Gyrus | brain |
5 | chr13:87482000-87482800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr13:87482200-87482400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr13:87482200-87482600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr13:87482200-87482800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr13:87482400-87482600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr13:87482400-87483800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |